Private equity takeovers linked to higher rates of patient harm in hospitals

Patients are more likely to fall, get new infections, or experience other forms of harm during their stay in a hospital after it is acquired by a private equity firm, according to a new study led by researchers at Harvard Medical School.

Mainz Biomed to Attend ESMO World Congress on Gastrointestinal Cancer 2023 in Barcelona, Spain – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Conference 28.06.2023 / 09:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

June 29, 2023

Gut bacteria may influence immunotherapy success in mesothelioma patients

A cancer study has found that certain gut bacteria may influence whether or not a patient’s immune system is successful in fighting mesothelioma, an aggressive

September 5, 2024

What are the odds we get an heir to Paxlovid?

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! Today, we look

July 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.